Just for the record, it should be obvious that when I offered the opinion that if we see sales of ten units a month "we'll be in great shape", all I meant was that this will be the turning point to greater exposure, and gradually to greater orders.
If we have demand for ten, this will quickly become a hundred, etc. My understanding of the company's strategy is that there will be a slow build-up directed by Medizone's own team, in order to be in a favorable position for the discussions with the Big Boys. This may coincide with further news about US patents, US hosptal test results, some results from bedbug tewsting, and news about the government application.
That's when the genuinely significant numbers come into play, both in terms of revenue and share price.